Commentary on “angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic”

Publication date: September–October 2020Source: Diabetes & Metabolic Syndrome: Clinical Research & Reviews, Volume 14, Issue 5Author(s): Carlos M. Ferrario
Source: Diabetes and Metabolic Syndrome: Clinical Research and Reviews - Category: Endocrinology Source Type: research